Mead Johnson (NYSE:MJN) was upgraded at Goldman Sachs (NYSE:GS) to buy form neutral with a price target of $95 as growth should rebound in China.
Shares are higher by about a tenth of a percent.
Perrigo (NASDAQ:PRGO) was upgraded at Morgan Stanley (NYSE:MS) to overweight from equal weight with a price target of $125 due to issues concerning its nutritionals division being resolved as well as strong potential for growth in the future.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.